Alphatec Holdings reported second-quarter total revenue of $214 million, up 15% year-over-year. Surgical revenue rose 17% to $196 million, driven by a 20% increase in case volume. The company posted a GAAP net loss of $26 million, while non-GAAP net income reached $11 million and adjusted EBITDA was $36 million, representing a 16.8% margin. Alphatec reaffirmed its full-year 2026 total revenue outlook of approximately $882 million and raised its adjusted EBITDA guidance to approximately $140 million from a prior expectation of approximately $134 million.
Alphatec Holdings IncRevenue growth and raised EBITDA guidance indicate strong financial performance.